Oscar Health Inc（OSCR）财务数据OSCROscar Health Inc

Evaluating the bottom line, Oscar Health, Inc. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 7.96%, while the net margin is 7.41%. These profitability ratios, combined with a Return on Equity (ROE) of 34.31%, provide a clear picture of how effectively OSCR converts its operational activities into shareholder value.

In the context of the broader market, OSCR competes directly with industry leaders such as MOH and ALHC. With a market capitalization of $10.11B, it holds a significant position in the sector. When comparing efficiency, OSCR's gross margin of N/A stands against MOH's 12.82% and ALHC's 12.96%. Such benchmarking helps identify whether Oscar Health, Inc. is trading at a premium or discount relative to its financial performance.

Oscar Health has shown significant revenue growth, with Q2 2026 revenue at $4.88 billion, up from $2.42 billion in Q3 2024. However, net income has fluctuated, with Q2 2026 reporting a net income of $361.8 million, following a loss in previous quarters. The net margin for Q2 2026 stands at 7.41%, which is a positive sign compared to previous losses.